Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)
China
· Delayed Price · Currency is CNY 22.69
+0.99 (4.56%)
At close: Mar 10, 2026
SHE:002393 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 5,812 | 5,562 | 4,511 | 4,810 | 3,917 | 3,943 | Upgrade
|
| Market Cap Growth | 30.01% | 23.28% | -6.20% | 22.78% | -0.65% | 5.98% | Upgrade
|
| Enterprise Value | 3,841 | 3,591 | 2,366 | 2,736 | 2,490 | 2,354 | Upgrade
|
| Last Close Price | 22.69 | 21.42 | 17.03 | 17.58 | 14.16 | 14.17 | Upgrade
|
| PE Ratio | 14.01 | 13.29 | 24.45 | 13.29 | 41.85 | 32.29 | Upgrade
|
| Forward PE | - | 18.18 | 18.18 | 18.18 | 18.18 | 18.18 | Upgrade
|
| PS Ratio | 4.17 | 3.99 | 3.38 | 4.17 | 3.42 | 3.61 | Upgrade
|
| PB Ratio | 1.16 | 1.11 | 0.94 | 0.98 | 0.90 | 0.89 | Upgrade
|
| P/TBV Ratio | 1.23 | 1.18 | 1.00 | 1.01 | 0.93 | 0.92 | Upgrade
|
| P/FCF Ratio | - | - | 130.71 | 34.78 | 13.49 | 36.48 | Upgrade
|
| P/OCF Ratio | - | - | 51.11 | 24.05 | 11.82 | 20.08 | Upgrade
|
| EV/Sales Ratio | 2.76 | 2.58 | 1.77 | 2.37 | 2.17 | 2.16 | Upgrade
|
| EV/EBITDA Ratio | 7.02 | 6.57 | 15.49 | 14.79 | 19.73 | 26.77 | Upgrade
|
| EV/EBIT Ratio | 8.17 | 7.64 | 31.24 | 23.07 | 40.80 | 82.13 | Upgrade
|
| EV/FCF Ratio | - | - | 68.54 | 19.79 | 8.57 | 21.78 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.06 | 0.06 | 0.33 | 0.18 | 0.35 | 0.39 | Upgrade
|
| Debt / FCF Ratio | - | - | 1.48 | 0.24 | 0.16 | 0.32 | Upgrade
|
| Net Debt / Equity Ratio | -0.40 | -0.40 | -0.47 | -0.45 | -0.45 | -0.37 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.66 | -3.66 | -14.68 | -11.82 | -15.43 | -18.39 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -64.96 | -15.81 | -6.71 | -14.96 | Upgrade
|
| Asset Turnover | - | - | 0.23 | 0.21 | 0.22 | 0.21 | Upgrade
|
| Inventory Turnover | - | - | 3.12 | 2.60 | 2.39 | 2.03 | Upgrade
|
| Quick Ratio | - | - | 3.65 | 4.05 | 3.28 | 3.75 | Upgrade
|
| Current Ratio | - | - | 4.10 | 4.50 | 3.60 | 4.26 | Upgrade
|
| Return on Equity (ROE) | 8.54% | 8.54% | 3.83% | 7.82% | 2.14% | 2.80% | Upgrade
|
| Return on Assets (ROA) | - | - | 0.82% | 1.34% | 0.73% | 0.35% | Upgrade
|
| Return on Invested Capital (ROIC) | 14.37% | 15.50% | 2.47% | 3.99% | 1.86% | 0.92% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 1.50% | 2.30% | 1.30% | 0.60% | Upgrade
|
| Earnings Yield | 7.20% | 7.52% | 4.09% | 7.52% | 2.39% | 3.10% | Upgrade
|
| FCF Yield | - | - | 0.77% | 2.88% | 7.41% | 2.74% | Upgrade
|
| Dividend Yield | 1.61% | - | 2.05% | 2.44% | 1.51% | 1.51% | Upgrade
|
| Payout Ratio | - | - | 65.59% | 15.13% | 58.48% | 14.94% | Upgrade
|
| Buyback Yield / Dilution | -0.77% | -0.77% | 0.83% | -0.58% | -0.71% | -5.72% | Upgrade
|
| Total Shareholder Return | 0.81% | -0.77% | 2.89% | 1.85% | 0.80% | -4.21% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.